Your browser doesn't support javascript.
loading
Immune Checkpoint Inhibitor-induced Reinvigoration of Tumor-infiltrating CD8+ T Cells is Determined by Their Differentiation Status in Glioblastoma.
Park, Junsik; Kwon, Minsuk; Kim, Kyung Hwan; Kim, Tae-Shin; Hong, Seon-Hui; Kim, Chang Gon; Kang, Seok-Gu; Moon, Ju Hyung; Kim, Eui Hyun; Park, Su-Hyung; Chang, Jong Hee; Shin, Eui-Cheol.
Afiliación
  • Park J; Laboratory of Immunology and Infectious Diseases, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
  • Kwon M; Laboratory of Immunology and Infectious Diseases, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
  • Kim KH; Laboratory of Immunology and Infectious Diseases, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
  • Kim TS; Laboratory of Immunology and Infectious Diseases, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
  • Hong SH; BioMedical Science and Engineering Interdisciplinary Program, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
  • Kim CG; Laboratory of Translational Immunology and Vaccinology, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
  • Kang SG; Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Moon JH; Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Kim EH; Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Park SH; Laboratory of Translational Immunology and Vaccinology, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
  • Chang JH; Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Republic of Korea. ecshin@kaist.ac.kr CHANGJH@yuhs.ac.
  • Shin EC; Laboratory of Immunology and Infectious Diseases, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea. ecshin@kaist.ac.kr CHANGJH@yuhs.ac.
Clin Cancer Res ; 25(8): 2549-2559, 2019 04 15.
Article en En | MEDLINE | ID: mdl-30659023
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_brain_nervous_system_cancer Asunto principal: Linfocitos Infiltrantes de Tumor / Glioblastoma / Linfocitos T CD8-positivos / Antineoplásicos Inmunológicos Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_brain_nervous_system_cancer Asunto principal: Linfocitos Infiltrantes de Tumor / Glioblastoma / Linfocitos T CD8-positivos / Antineoplásicos Inmunológicos Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article